Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6C pseudogene 2 (COX6CP2) is a human gene classified as a pseudogene, meaning it is highly similar in DNA sequence to the functional *cytochrome c oxidase subunit 6C* gene but carries mutations that prevent it from encoding a functional protein[1]. Pseudogenes such as COX6CP2 may occasionally be transcribed and can possibly participate in gene regulation through noncoding RNAs, but they generally do not serve as protein-coding therapeutic targets[6]. No known drugs interact with COX6CP2, nor is it considered a biomarker or safety concern for therapeutic applications[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C pseudogene 2 (COX6CP2).